Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
13°
Partly Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Dare Bioscience Inc
(NQ:
DARE
)
3.230
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1
Open
3.230
Bid (Size)
3.180 (10)
Ask (Size)
3.900 (4)
Prev. Close
3.230
Today's Range
3.230 - 3.230
52wk Range
3.050 - 7.560
Shares Outstanding
70,521,979
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Earnings Scheduled For November 14, 2024
November 14, 2024
Via
Benzinga
Insights into Dare Bioscience's Upcoming Earnings
November 13, 2024
Via
Benzinga
Performance
YTD
-18.16%
-18.16%
1 Month
-12.94%
-12.94%
3 Month
-5.56%
-5.56%
6 Month
-40.79%
-40.79%
1 Year
-18.90%
-18.90%
More News
Read More
DARE Stock Earnings: Dare Bioscience Beats Revenue for Q2 2024
August 12, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
May 30, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
May 21, 2024
Via
Benzinga
Bayer Highlights Detailed Data From Twin Late-Stage Trials On Experimental Menopause Candidate, Seeks Regulatory Approval
May 17, 2024
Via
Benzinga
Recap: Dare Bioscience Q4 Earnings
March 28, 2024
Via
Benzinga
Dare Bioscience Earnings Preview
March 27, 2024
Via
Benzinga
Earnings Outlook For Dare Bioscience
November 08, 2023
Via
Benzinga
Why James Hardie Industries Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
May 21, 2024
Via
Benzinga
DARE Stock Earnings: Dare Bioscience Misses EPS, Beats Revenue for Q1 2024
May 14, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 30, 2024
Via
Benzinga
Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 30, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
April 25, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
April 24, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
April 17, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
March 28, 2024
Via
Benzinga
DARE Stock Earnings: Dare Bioscience Beats EPS, Beats Revenue for Q4 2023
March 28, 2024
Via
InvestorPlace
First Lady Jill Biden Unveils $100M In Federal Funding To Support R&D - Watch Out for These Women Health Stocks
February 21, 2024
Via
Benzinga
Earnings Scheduled For March 28, 2024
March 28, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
February 01, 2024
Via
InvestorPlace
Daré Bioscience Highlights Efficacy Data From Treatment Candidate For Painful Menstruation
December 20, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 20, 2023
Via
Benzinga
FDA Gives Nod To Daré Bioscience's Trial Of Non-Hormonal Treatment For Dyspareunia, Seeks Additional Funding
December 07, 2023
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 07, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
